Ikeguchi M, Fukuda K, Oka S, Yamaguchi K, Hisamitsu K, Tsujitani S, Sakatani T, Ueda T, Kaibara N
First Department of Surgery, Faculty of Medicine, Tottori University, Yonago, Japan.
Oncology. 2001;61(1):71-8. doi: 10.1159/000055356.
An estrogen-regulated lysosomal protease, cathepsin D, has been detected in a variety of tissues. This proteinase has been described as closely associated with tumor progression and metastasis in malignant tumors. The purpose of this study was to determine the clinicopathological and prognostic significance of cathepsin D expression in gastric adenocarcinoma.
In a consecutive series of 478 patients with gastric carcinoma (median follow-up period: 93 months, range: 1-285 months), cathepsin D expression in tumors was quantitatively analyzed with immunohistochemistry using a monoclonal antibody against cathepsin D (clone: 1C11). The percentage of cathepsin-D-positive cancer cells (the CD index) was calculated. In addition, the amount of cathepsin-D-positive stromal cells was evaluated; three grades (high, intermediate, and low) were used for the classification.
The mean CD index of 478 tumors was 12.8% (range: 0-100%, median: 8%). The mean CD index of diffuse-type gastric carcinomas (14.9%) was significantly higher than that of intestinal-type carcinomas (10.1%, p < 0.0001). Cathepsin D expression of cancer cells was significantly associated with the depth of tumor invasion in both types. The percentage of tumors with high cathepsin D expression in stromal cells was significantly higher in well-differentiated tumors (25.5%) than in moderately differentiated (12.8%) or in poorly differentiated tumors (19.1%). Cathepsin D expression of stromal cells was significantly associated with the depth of tumor invasion in the intestinal type, in contrast to the diffuse type. Highly expressed cathepsin D in cancer cells was associated with a poor prognosis in both types of carcinoma, but in stromal cells highly expressed cathepsin D was associated to a poor prognosis in the intestinal type only.
These results indicate that cathepsin D expression in cancer cells may play an important role in tumor progression in diffuse-type gastric carcinoma, whereas in the intestinal type of carcinoma, cathepsin D expression in stromal cells may play an important role in tumor progression.
在多种组织中检测到一种雌激素调节的溶酶体蛋白酶——组织蛋白酶D。该蛋白酶被认为与恶性肿瘤的进展和转移密切相关。本研究旨在确定组织蛋白酶D在胃腺癌中的临床病理及预后意义。
连续纳入478例胃癌患者(中位随访时间:93个月,范围:1 - 285个月),使用抗组织蛋白酶D的单克隆抗体(克隆号:1C11)通过免疫组化对肿瘤中的组织蛋白酶D表达进行定量分析。计算组织蛋白酶D阳性癌细胞的百分比(CD指数)。此外,评估组织蛋白酶D阳性基质细胞的数量;采用三个等级(高、中、低)进行分类。
478例肿瘤的平均CD指数为12.8%(范围:0 - 100%,中位数:8%)。弥漫型胃癌的平均CD指数(14.9%)显著高于肠型癌(10.1%,p < 0.0001)。两种类型中癌细胞的组织蛋白酶D表达均与肿瘤浸润深度显著相关。高分化肿瘤中基质细胞组织蛋白酶D高表达的肿瘤百分比(25.5%)显著高于中分化(12.8%)或低分化肿瘤(19.1%)。与弥漫型相反,基质细胞的组织蛋白酶D表达在肠型中与肿瘤浸润深度显著相关。癌细胞中高表达的组织蛋白酶D与两种类型的癌预后不良相关,但在基质细胞中,高表达的组织蛋白酶D仅与肠型癌的预后不良相关。
这些结果表明,癌细胞中的组织蛋白酶D表达可能在弥漫型胃癌的肿瘤进展中起重要作用,而在肠型癌中,基质细胞中的组织蛋白酶D表达可能在肿瘤进展中起重要作用。